Migraines are often thought of as simply a “bad headache.” However, contrary to this common belief, they’re not. A migraine is comprised of multiple neurological symptoms – usually including a severe throbbing, and persistent pain on one side of the head. Migraine attacks can last from 4 hours, to as long as 72 hours.

You Probably Know More Sufferers Than You May Be Aware Of:

  • Migraines are the 3rd most prevalent neurological condition in the world
  • 12% of the US population (including 10% of children) suffer from migraines
  • Migraines are often hereditary
  • 18% of American women fall victim to migraines (compared to 6% of men)

Migraines Can be really, really debilitating

  • Migraines are the 6th most disabling illness in the world (Migraine Research Foundation)
  • 10% of sufferers have chronic migraine, (15+ migraine days per month)
  • 90% of sufferers cannot work or function normally during their migraines

Migraines are Still Largely a Medical mystery

  • More than half of all sufferers are never diagnosed with migraines
  • Many sufferers never seek medical attention for their pain
  • Only 4% of migraine sufferers ever seek a headache specialist

Despite migraines still being a medical mystery, there are new treatments being investigated. Rochester Clinical Research is at the forefront of this research. Check out the studies below and call 288-0890 to see if you qualify.

See below for current research studies.

Pediatric Migraine Study

Children shouldn’t have to deal with chronic pain. RCR is currently enrolling adolescents that are seeking relief for migraines. They must be between the ages of 6 & 17 and have a history of migraines. The study will last approximately 4 months and compensation is available for those who qualify.

View Trial Details
Ages 6 – 17
Compensation* $225
Study Topics Pediatric Migraine

*Compensation for time and travel may be available to those who qualify.

Migraine Relief

The purpose of this study will be to evaluate the safety and efficacy of a study drug that aims to provide migraine relief. The study will last approximately 17 weeks with 4 visits to our office and 1 telephone call.

View Trial Details
Ages 18 – 75
Compensation* $225
Study Topics Migraine

*Compensation for time and travel may be available to those who qualify.

Intranasal Migraine Treatment

The purpose of this research study is to examine an investigational nasal spray for the treatment of one acute migraine headache. Rochester Clinical Research is currently enrolling individuals over the age of 18 years old who experience 2-8 migraines per month. The study drug is a CGRP receptor blocker administered through a nasal spray.

View Trial Details
Ages 18+
Study Topics Migraine